Trial halted: new scan tested for better cancer detection
NCT ID NCT06125028
Summary
This study aimed to test whether a new PET scan imaging agent called [68Ga]Ga-PTF could better detect and stage marginal zone lymphoma compared to the standard FDG PET scan. The trial involved 13 adult patients with newly diagnosed lymphoma who had not yet received treatment. Participants received both types of scans in random order so researchers could compare how accurately each method found cancer spread.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU La Timone
Marseille, 13005, France
-
CHU de Bordeaux
Bordeaux, 33600, France
-
CHU de Nantes
Nantes, 44093, France
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168, Italy
-
Hôpital Cochin
Paris, 75014, France
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138, Italy
-
L'IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l
Meldola, 47014, Italy
-
Medizinische Universität Innsbruck
Innsbruck, 6020, Austria
-
Ospedale San Raffaele S.r.l.
Milan, 20132, Italy
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Würzburg
Würzburg, 97080, Germany
Conditions
Explore the condition pages connected to this study.